Your browser doesn't support javascript.
loading
Silent IL2RG Gene Editing in Human Pluripotent Stem Cells.
Li, Li B; Ma, Chao; Awong, Geneve; Kennedy, Marion; Gornalusse, German; Keller, Gordon; Kaufman, Dan S; Russell, David W.
Afiliação
  • Li LB; Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Ma C; College of Veterinary Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
  • Awong G; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
  • Kennedy M; McEwen Centre for Regenerative Medicine, University Health Network, Toronto, Ontario, Canada.
  • Gornalusse G; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Keller G; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Kaufman DS; Current address: Sunnybrook Research Institute, Toronto, Ontario, Canada.
  • Russell DW; McEwen Centre for Regenerative Medicine, University Health Network, Toronto, Ontario, Canada.
Mol Ther ; 24(3): 582-91, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26444081
Many applications of pluripotent stem cells (PSCs) require efficient editing of silent chromosomal genes. Here, we show that a major limitation in isolating edited clones is silencing of the selectable marker cassette after homologous recombination and that this can be overcome by using a ubiquitous chromatin opening element (UCOE) promoter-driven transgene. We use this strategy to edit the silent IL2RG locus in human PSCs with a recombinant adeno-associated virus (rAAV)-targeting vector in the absence of potentially genotoxic, site-specific nucleases and show that IL2RG is required for natural killer and T-cell differentiation of human PSCs. Insertion of an active UCOE promoter into a silent locus altered the histone modification and cytosine methylation pattern of surrounding chromatin, but these changes resolved when the UCOE promoter was removed. This same approach could be used to correct IL2RG mutations in X-linked severe combined immunodeficiency patient-derived induced PSCs (iPSCs), to prevent graft versus host disease in regenerative medicine applications, or to edit other silent genes.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inativação Gênica / Células-Tronco Pluripotentes / Subunidade gama Comum de Receptores de Interleucina / Edição de Genes Limite: Humans Idioma: En Revista: Mol Ther Assunto da revista: BIOLOGIA MOLECULAR / TERAPEUTICA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inativação Gênica / Células-Tronco Pluripotentes / Subunidade gama Comum de Receptores de Interleucina / Edição de Genes Limite: Humans Idioma: En Revista: Mol Ther Assunto da revista: BIOLOGIA MOLECULAR / TERAPEUTICA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos